» Authors » Gad A Marshall

Gad A Marshall

Explore the profile of Gad A Marshall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 4281
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarkis R, Orozco J, Lemus H, Hankerson A, Liu L, Lam A, et al.
Brain Commun . 2025 Feb; 7(1):fcaf050. PMID: 39944741
Late-onset epilepsy has been linked with accelerated cognitive decline and a higher risk of dementia. In this study, we sought to characterize the cognitive profile of participants with late-onset unexplained...
2.
Weizenbaum E, Hsieh S, Molinare C, Soberanes D, Christiano C, Viera A, et al.
J Prev Alzheimers Dis . 2025 Jan; 12(3):100057. PMID: 39809614
Background: The multi-day Boston Remote Assessment of Neurocognitive Health (BRANCH) is a remote, web-based assessment designed to capture the earliest cognitive changes in the preclinical stage of Alzheimer's disease (AD)....
3.
Jutten R, Soberanes D, Molinare C, Hsieh S, Farrell M, Schultz A, et al.
NPJ Digit Med . 2025 Jan; 8(1):24. PMID: 39806194
Remote, digital cognitive testing on an individual's own device provides the opportunity to deploy previously understudied but promising cognitive paradigms in preclinical Alzheimer's disease (AD). The Boston Remote Assessment for...
4.
Marshall G
Continuum (Minneap Minn) . 2024 Dec; 30(6):1744-1760. PMID: 39620842
Objective: This article discusses the prevalence, pathophysiology, assessment, and management of neuropsychiatric symptoms in patients with dementia. Latest Developments: There is a growing body of evidence localizing neuropsychiatric symptoms in...
5.
Du X, Novoa-Laurentiev J, Plasek J, Chuang Y, Wang L, Marshall G, et al.
EBioMedicine . 2024 Oct; 109:105401. PMID: 39396423
Background: Large language models (LLMs) have shown promising performance in various healthcare domains, but their effectiveness in identifying specific clinical conditions in real medical records is less explored. This study...
6.
Munro C, Farrell M, Hanseeuw B, Rentz D, Buckley R, Properzi M, et al.
JAMA Netw Open . 2024 Aug; 7(8):e2427248. PMID: 39207757
Importance: Depressive symptoms in older adults may be a harbinger of Alzheimer disease (AD), even in preclinical stages. It is unclear whether worsening depressive symptoms are manifestations of regional distributions...
7.
Wang L, Yang R, Sha Z, Kuraszkiewicz A, Leonik C, Zhou L, et al.
Res Sq . 2024 Aug; PMID: 39149490
Background: The data and information contained within electronic health records (EHR) provide a rich, diverse, longitudinal view of real-world patient histories, offering valuable opportunities to study antecedent risk factors for...
8.
Dubbelman M, Diez I, Gonzalez C, Amariglio R, Becker J, Chhatwal J, et al.
Front Aging Neurosci . 2024 Jun; 16:1420290. PMID: 38934017
Background: Changes in everyday functioning constitute a clinically meaningful outcome, even in the early stages of Alzheimer's disease. Performance-based assessments of everyday functioning might help uncover these early changes. We...
9.
Jadick M, Robinson T, Farrell M, Klinger H, Buckley R, Marshall G, et al.
Neurology . 2024 May; 102(12):e209447. PMID: 38810211
Background And Objectives: Self-reported cognitive decline is an early behavioral manifestation of Alzheimer disease (AD) at the preclinical stage, often believed to precede concerns reported by a study partner. Previous...
10.
Wang S, Mimmack K, Cacciamani F, Elnemais Fawzy M, Munro C, Gatchel J, et al.
Front Aging Neurosci . 2024 Mar; 16:1335878. PMID: 38511196
Introduction: Both the loss of awareness for cognitive decline (a. k.a anosognosia) and neuropsychiatric symptoms (NPS) are common in patients with Alzheimer's disease (AD) dementia, even in prodromal stages, and...